Abstract
Baseline level of the cysteinyl leukotriene (CysLT), leukotriene E 4 (LTE4), is associated with an increased pain rate in children and adults with sickle cell disease (SCD). To provide additional evidence for a role of CysLTs in the pathogenesis of vaso-occlusion, we tested the hypothesis that LTE4 levels will increase within an individual during painful episodes compared to baseline. In a cohort of 19 children and adults with SCD, median LTE4 levels increased from 82.36 pg/mg creatinine at baseline to 162.81 pg/mg creatinine during a painful episode (P < 0.001). These data further support a contribution of CysLTs to the process of vaso-occlusion. © 2009 Wiley-Liss, Inc.
Cite
CITATION STYLE
Field, J. J., Strunk, R. C., Knight-Perry, J. E., Blinder, M. A., Townsend, R. R., & DeBaun, M. R. (2009). Urinary cysteinyl leukotriene E4 significantly increases during pain in children and adults with sickle cell disease. American Journal of Hematology, 84(4), 231–233. https://doi.org/10.1002/ajh.21370
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.